Tag: Therapeutics

Digital Therapeutics: Are We Building What Matters?

As a venture capitalist, I don’t scream all the time — I only scream when investing in digital therapeutics. Obviously, that’s a joke. I believe in digital therapeutics. At one or several points in our lives, every one of us will face medical conditions where DTx may be the ther...

Report Card #39: Charm Therapeutics

Welcome to the AI GradeBook, where we delve into the fascinating world of Artificial Intelligence throughout several industries. Our AI Report Card (AIRC) is designed to provide a comprehensive and insightful look at how companies embrace AI across various facets of their operations. ...

Enlaza Therapeutics

The War-Lock platform works by incorporating proprietary unnatural amino acids into therapeutic proteins. These unnatural amino acids act as tethering points that enable the biologic to covalently bind to its target. The amino acids are engineered to have low intrinsic reactivity so they will not in...

Reverb Therapeutics — Redirecting endogenous cytokines

This week, we are excited to launch our latest company — Reverb Therapeutics. Reverb is the culmination of a 15-month internal company creation effort, working closely with highly experienced, repeat entrepreneurs in David de Graaf and Surjit Dixit to build a new platf...

Cheers to Sarepeta Therapeutics: My Rock and Lifesaver!

I’ve got some serious love to share today. Let’s talk about Sarepeta Therapeutics, straight out of the awesome city of Cambridge, Massachusetts. These incredible folks have been a true-blue supporter, always there, always believing. And oh boy, they’ve got a special place in my hea...